| Literature DB >> 34350225 |
Yu Lian1, Marta Gòdia1, Anna Castello1,2, Joan Enric Rodriguez-Gil3, Sam Balasch4, Armand Sanchez1,2, Alex Clop1,5.
Abstract
RNA-Seq data from human semen suggests that the study of the sperm transcriptome requires the previous elimination from the ejaculates of somatic cells carrying a larger load of RNA. Semen purification is also carried to study the sperm transcriptome in other species including swine and it is often done by density gradient centrifugation to obtain viable spermatozoa from fresh ejaculates or artificial insemination doses, thereby limiting the throughput and remoteness of the samples that can be processed in one study. The aim of this work was to evaluate the impact of purification with density gradient centrifugation by BoviPureTM on porcine sperm. Four boar ejaculates were purified with BoviPureTM and their transcriptome sequenced by RNA-Seq was compared with the RNA-Seq profiles of their paired non-purified sample. Seven thousand five hundred and nineteen protein coding genes were identified. Correlation, cluster, and principal component analysis indicated high-although not complete-similarity between the purified and the paired non-purified ejaculates. 372 genes displayed differentially abundant RNA levels between treatments. Most of these genes had lower abundances after purification and were mostly related to translation, transcription and metabolic processes. We detected a significant change in the proportion of genes of epididymal origin within the differentially abundant genes (1.3%) when compared with the catalog of unaltered genes (0.2%). In contrast, the proportion of testis-specific genes was higher in the group of unaltered genes (4%) when compared to the list of differentially abundant genes (0%). No proportion differences were identified for prostate, white blood, lymph node, tonsil, duodenum, skeletal muscle, liver, and mammary gland. Altogether, these results suggest that the purification impacts on the RNA levels of a small number of genes which are most likely caused by the removal of epididymal epithelial cells but also premature germinal cells, immature or abnormal spermatozoa or seminal exosomes with a distinct load of RNAs.Entities:
Keywords: RNA-Seq; differentially abundant gene; exosome; germline cell; somatic cell; sperm RNA; sperm purification
Year: 2021 PMID: 34350225 PMCID: PMC8326511 DOI: 10.3389/fvets.2021.668158
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Figure 1Linear regression and Pearson correlation of the transcriptome profiles between the purified and non-purified aliquots for the four ejaculates. The Pearson correlation and its p-value are annotated at the top left of each plot.
Figure 2Grouping of the sperm transcriptomes of the eight samples. (A) Cluster analysis and the Selective Inference p-values. (B) Principal Component Analysis biplot.
Ten most differentially abundant genes with FPKM ≥ 10 between the purified and paired non-purified samples.
| ENSSSCG00000041806 | – | 5.74E-14 | 40 | 0.06 | 0.11 | 0.29 | 0.17 | 0.16 | |
| ENSSSCG00000037274 | Prothymosin Alpha ( | 2.31E-12 | 32 | 0.08 | 0.31 | 0.14 | 0.07 | 0.15 | Quite ubiquotous but mostly expressed in EBV-transformed lymphocytes. Low expression in testis. |
| ENSSSCG00000005373 | N-Acetylneuraminate Synthase ( | 2.31E-12 | 16 | 0.03 | 0.23 | 0.30 | 0.10 | 0.16 | Highest expression in the prostate and colon. |
| ENSSSCG00000009019 | Ribosomal Protein S3A ( | 2.92E-12 | 13 | 0.10 | 0.26 | 0.17 | 0.06 | 0.15 | Mostly expressed in the female reproductive organs and EBV-transformed lymphocytes. |
| ENSSSCG00000032111 | Ribosomal Protein L7 | 1.86E-11 | 15 | 0.09 | 0.47 | 0.14 | 0.14 | 0.21 | Mostly expressed in the female reproductive organs and EBV-transformed lymphocytes. |
| ENSSSCG00000012119 | Thymosin Beta 4 X-Linked ( | 3.66E-11 | 16 | 0.09 | 0.16 | 0.12 | 0.20 | 0.14 | Mostly expressed in EBV-transformed lymphocytes, spleen, lung, and whole blood. |
| ENSSSCG00000004489 | Eukaryotic Translation Elongation Factor 1 Alpha 1 ( | 4.45E-11 | 93 | 0.07 | 0.48 | 0.29 | 0.10 | 0.24 | Mostly expressed in cultured fibroblasts, EBV-transformed lymphocytes, ovary, and uterus. |
| ENSSSCG00000033019 | Ribosomal Protein L12 ( | 5.8E-11 | 16 | 0.05 | 0.20 | 0.17 | 0.10 | 0.13 | Most highly expressed in EBV-transformed lymphocytes, ovary, cultured fibroblasts, and cervix. |
| ENSSSCG00000029724 | Receptor For Activated C Kinase 1 ( | 6.6E-11 | 19 | 0.09 | 0.26 | 0.28 | 0.17 | 0.20 | Most highly expressed in ovary, EBV-transformed lymphocytes, cultured fibroblasts, and cervix. |
| ENSSSCG00000031088 | Ribosomal Protein S7 ( | 7.0E-11 | 81 | 0.10 | 0.58 | 0.33 | 0.28 | 0.32 | Most highly expressed in ovary, EBV-transformed lymphocytes and cultured fibroblasts. |
B1 P/NP, Ratio of the FPKM in the purified and the FPKM in the non-purified in B1; B2 P/NP, Ratio of the FPKM in purified and the FPKM in non-purified in B2; B3 P/NP, Ratio of the FPKM in purified and the FPKM in non-purified in B3; B4 P/NP, Ratio of the FPKM in purified and the FPKM in non-purified in B4; Average P/NP, Average of the ratio of the FPKM in purified and the FPKM in non-purified in the four samples.
Number of tissue-specific or nearly tissue-specific genes in the DAG and non-DAG groups and p-value of the comparison of the proportion of these genes in both groups.
| Epididymis | 57 | 18 | N/A | N/A | 5 | 13 | 0.001 |
| Skeletal muscle | 48 | 6 | N/A | N/A | 0 | 6 | 1 |
| Duodenum | 5 | 2 | N/A | N/A | 0 | 2 | 1 |
| Lymph node | 1 | 0 | 14 | 1 | 0 | 1 | 1 |
| Tonsils | 5 | 0 | 50 | 10 | 2 | 8 | 0.08 |
| Testis | 908 | 295 | N/A | N/A | 0 | 295 | 5.40E-07 |
| Prostate | 5 | 0 | 16 | 3 | 1 | 2 | 0.14 |
| EBV transformed lymphocytes | 13 | 0 | 149 | 40 | 0 | 40 | 0.26 |
| Whole blood | 7 | 0 | 105 | 6 | 0 | 6 | 1 |
| Mammary | 0 | 0 | 7 | 0 | 0 | 0 | 1 |
| Liver | 85 | 3 | N/A | N/A | 0 | 3 | 1 |
| Nerve tibial | 2 | 1 | N/A | N/A | 0 | 1 | 1 |
Number in DAG, number of tissue-specific or nearly tissue-specific genes in the DAG group. Number in non-DAG, number of tissue-specific or nearly tissue-specific genes in the non-DAG group. P-value, P-value of the two-tailed Fisher's Exact Test comparing the proportion of tissue specific or nearly tissue-specific genes in the DAG vs. the non-DAG groups. N/A, non applicable.